SCHEMBL4175075

SCHEMBL4175075

N#Cc1cccc(OCC2CCCN(C(=O)c3csc(NS(=O)(=O)c4ccccc4)n3)C2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.43
ALDH1A1 P00352 4/20 0.41
PKM P14618 1/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
KCNQ1 P51787 1/20 0.40
CPT2 P23786 1/20 0.40
CPT1A P50416 1/20 0.40
CPT1B Q92523 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
MGLL Q99685 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CCKBR P32239 1/20 0.38
KAT6A Q92794 1/20 0.37
TRPC3 Q13507 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4176042 0.92 ALDH1A1 (0.47) GAAALDH1A1PKMHCRTR1HCRTR2
SCHEMBL4184017 0.88 KAT6A (0.42) GAAKCNQ1CPT2CPT1ACPT1B
SCHEMBL4173029 0.87 HCRTR1 (0.55) GAAALDH1A1PKMHCRTR1HCRTR2
SCHEMBL4173760 0.86 HCRTR1 (0.46) GAAALDH1A1PKMHCRTR1HCRTR2
SCHEMBL3163254 0.82 SCN9A (0.46) ALDH1A1PKMHTTTDP1MEN1
SCHEMBL4177379 0.82 GAA (0.56) GAAALDH1A1PKMLMNAHTT
SCHEMBL4171049 0.80 ALDH1A1 (0.43) GAAALDH1A1PKMLMNAHTT
SCHEMBL4176879 0.79 ALDH1A1 (0.53) GAAALDH1A1PKMHTTTDP1
SCHEMBL4178010 0.78 TRPC3 (0.51) GAAALDH1A1PKMLMNAHTT
SCHEMBL4178536 0.78 TRPC3 (0.42) GAAALDH1A1PKMHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357711-B2 Heterocyclic sulfonamides as inhibitors of ion channels PFIZER LIMITED (GB) 2013-01-22 US disclosed
US-20090143358-A1 INHIBITORS OF ION CHANNELS ICAGEN, INC. (US) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143358-A1 INHIBITORS OF ION CHANNELS TRPV1, TRPV5, TRPA1 GAA 3679/4885ALDH1A1 3113/4885PKM 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.